These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5754832)

  • 1. Generic drugs and therapeutic equivalence.
    Friend DG
    JAMA; 1968 Nov; 206(8):1785. PubMed ID: 5754832
    [No Abstract]   [Full Text] [Related]  

  • 2. 2013 State Compounding Legislation Tracker.
    Miller DG
    Int J Pharm Compd; 2013; 17(5):375-8. PubMed ID: 24459782
    [No Abstract]   [Full Text] [Related]  

  • 3. The "generic equivalency" game.
    Dembicki EL
    J Psychiatr Nurs Ment Health Serv; 1968; 6(6):369-71. PubMed ID: 4302148
    [No Abstract]   [Full Text] [Related]  

  • 4. Basics of compounding: repackaging, part 2.
    Allen LV
    Int J Pharm Compd; 2013; 17(2):136-40. PubMed ID: 23696175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Perspectives in Compounding: Compounding Gains and Losses Since I Met "Careless arithmetic nullifies careful compounding".
    Newton DW
    Int J Pharm Compd; 2015; 19(6):444-6. PubMed ID: 26891557
    [No Abstract]   [Full Text] [Related]  

  • 6. New recommendations to modernize drug manufacturing.
    FDA Consum; 2007; 41(1):4. PubMed ID: 17354283
    [No Abstract]   [Full Text] [Related]  

  • 7. Compounding pharmacies: before and after an inspection.
    Kulkarni D; Ricketts S
    Int J Pharm Compd; 2013; 17(5):358-62. PubMed ID: 24459779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 9. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
    Kastango ES
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protecting consumers from counterfeit drugs.
    FDA Consum; 2004; 38(3):12-3. PubMed ID: 15218838
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA, states discuss pharmacy compounding regulatory framework.
    Traynor K
    Am J Health Syst Pharm; 2013 Feb; 70(3):180, 182. PubMed ID: 23327976
    [No Abstract]   [Full Text] [Related]  

  • 12. GMPs vs GCPs: manufacturing and compounding definitions.
    Allen LV
    Int J Pharm Compd; 2013; 17(5):356. PubMed ID: 24459778
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drugs for children--when temporary solutions become routine].
    Kalikstad B; Westergren T
    Tidsskr Nor Laegeforen; 2006 Mar; 126(7):930-2. PubMed ID: 16554887
    [No Abstract]   [Full Text] [Related]  

  • 14. Report on the PQRI impurity characterization and quantification best practices survey.
    Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
    Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
    [No Abstract]   [Full Text] [Related]  

  • 15. GMPs vs GCPs: United States Pharmacopeia General Chapters.
    Allen LV
    Int J Pharm Compd; 2013; 17(5):439. PubMed ID: 24459791
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug product quality.
    Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
    [No Abstract]   [Full Text] [Related]  

  • 17. The Third Policy Arena: Standard-Setting Organizations.
    Consult Pharm; 2016 Mar; 31(3):176. PubMed ID: 26975597
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of compounding on sterility and stability of drugs.
    Hardee GE
    J Am Vet Med Assoc; 1994 Jul; 205(2):224-5. PubMed ID: 7928582
    [No Abstract]   [Full Text] [Related]  

  • 19. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
    Hyde TD
    Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of Brazilian Requirements for Therapeutic Equivalence of Orally Inhaled and Nasal Drug Products.
    Silva MC; Costa HS; Valadares BN; Grecchi L; Nagao L; Santos GML
    AAPS PharmSciTech; 2019 Jun; 20(6):235. PubMed ID: 31236849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.